XyloCor taps SmartWise’s infusion device for gene therapy administration
XyloCor will pay approximately $130m in upfront and milestone-based payments to SmartCella for the supply of Extroducer infusion system.
Healthcare
Gay and bisexual men have higher risk of anxiety and depression
Why has New Zealand U-turned on the world’s first smoking ban?
THL signs $2.5bn takeover deal for US healthtech company Agiliti
Nano arthroscopy: transforming orthopaedic care with minimally invasive excellence
Revolutionising healthcare: bioprinting takes a leap forward in 2024
Angle secures Eisai contract for Portrait HER2 assay
Wearable technology growing in importance for medical uses
